Sara Ng: Moving Beyond Management to Stewardship – “Advancing Anticoagulation Stewardship” Released by NQF
Sara Ng, Clinical and Laboratory Haematologist, Director of Thrombosis and Haemostasis at South Western Sydney Local Health District, shared a post by Anticoagulation Forum on LinkedIn:
“Moving Beyond “Management” to “Stewardship”
Anticoagulants are life-saving, but they remain a top cause of adverse drug events. It’s time to upgrade our approach. The Joint Commission and the National Quality Forum (NQF) have released “Advancing Anticoagulation Stewardship: A Playbook.” This isn’t just about meeting National Patient Safety Goals — It is about building a resilient system that proactively prevents harm.
The 7 Core Elements of a Stewardship Program –
To truly protect our patients, we need to implement these foundational pillars:
1. Leadership Commitment: Securing resources (human, financial, tech) is the non-negotiable first step.
2. Accountability and Expertise: Appoint a single leader responsible for outcomes, supported by clinicians with deep hemostasis expertise.
3. Multidisciplinary Support: Break the silos. Pharmacy, Nursing, Hematology, and IT must work as one unit.
4. Data Tracking: You can’t fix what you don’t measure. Track performance, adverse events, and adherence to guidelines.
5. Systematic Care: Implement evidence-based protocols that are sustainable and standardized across the system.
6. Transitions of Care: The danger zone. Create robust safety nets for patients moving between hospital and home.
7. Education: Ensure every stakeholder—from the prescribing resident to the patient—understands the “why” and “how” of their therapy.
Why This Matters
We often focus on the drug (dosing, monitoring). Stewardship focuses on the system. By addressing barriers like limited data or fragmented communication, we can significantly reduce the risk of bleeding and thrombosis.”
Quoting Anticoagulation Forum‘s post:
“We are proud to have partnered with the National Quality Forum (NQF) on this important resource. It remains a valuable guide for organizations worldwide working to improve patient safety and implement evidence-based stewardship practices.
Explore the report here.”
More posts from Sara Ng on Hemostasis Today.
-
Jan 7, 2026, 13:57Joshua Muia: Delighted to Welcome X. Long Zheng for a Versiti Seminar on TTP
-
Jan 7, 2026, 13:40Marilena Vrana Invites You to IPPC2026
-
Jan 7, 2026, 13:32Carlos Villa Joins Versiti Blood Research Institute
-
Jan 7, 2026, 13:21Bartosz Hudzik: New Evidence on “Aspirin Failure” After Ischemic Stroke
-
Jan 7, 2026, 08:50Fahad Khaliq on When is Ticagrelor Preferred Over Other Antiplatelets
-
Jan 7, 2026, 06:41Zain Khalpey on AI Driven Risk Prediction for Optimization of Anticoagulation in LVAD
-
Jan 7, 2026, 05:47Michael Makris: The Wakley Prize Essay Published in Today’s Lancet is an Excellent Read
-
Jan 7, 2026, 05:36Pierre F Sabouret Shares A Study on the Risk of Cardiovascular Death in SIDs
-
Jan 7, 2026, 05:15Glaivy Batsuli Reflects on ASH25
